AusPAR: Benralizumab

Australian Public Assessment Report

AusPAR

AusPAR: Benralizumab [PDF, 2 MB]

AusPAR: Benralizumab [Word, 3.41 MB]

Attachment: Product Information: Benralizumab [PDF, 378.06 KB]

Attachment: Product Information: Benralizumab [Word, 5.25 MB]

Device/Product Name

Fasenra

Active ingredients

Benralizumab

AusPAR Date

21 February 2019

Published

21 May 2019

Submission Number

PM-2016-04636-1-5

Submission Type

New biological entity

Decision

Approved